Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network
Variability of Ventricular Mass, Volume, and Ejection Fraction in Pediatric Cardiomyopathy Patients (A Study Conducted by the Pediatric Heart Network)
Sponsor: Carelon Research
Listed as NCT00123071, this observational or N/A phase trial focuses on Cardiomyopathy, Dilated and remains completed. Sponsored by Carelon Research, it has been updated 9 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Aug 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Aug 2023 [monthly]
Completed
▶ Show 4 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Apr 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
May 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Carelon Research
- National Heart, Lung, and Blood Institute (NHLBI)
- Pediatric Heart Network
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Boston, United States
- • Charleston, United States
- • Durham, United States
- • New York, United States
- • Philadelphia, United States
- • Salt Lake City, United States
- • St Louis, United States
- • Toronto, Canada